cbdMD (YCBD) Cash from Financing Activities (2016 - 2025)
cbdMD (YCBD) reported Cash from Financing Activities of $2.1 million for Q4 2025, up 45.58% sequentially from $1.4 million in Q3 2025.
cbdMD (YCBD) Cash from Financing Activities (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Cash from Financing Activities data on file, last reported at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (up 173.01% YoY), and the FY2025 full-year result was $1.4 million, up 11.39% from the prior year.
- Cash from Financing Activities grew to $2.1 million in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $13.8 million in Q3 2021 to a low of -$1.1 million in Q4 2022.
- A 5-year average of $752267.8 and a median of -$619751.0 in 2021 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 142.35% in 2021 and jumped 144523500.0% in 2025, its largest moves.
- Tracing YCBD's Cash from Financing Activities over 5 years: stood at -$1.0 million in 2021, then dropped by 10.92% to -$1.1 million in 2022, then jumped by 99.78% to -$2501.0 in 2023, then soared by 100.04% to $1.0 in 2024, then soared by 210395600.0% to $2.1 million in 2025.
- Business Quant data shows YCBD's Cash from Financing Activities at $2.1 million in Q4 2025, $1.4 million in Q3 2025, and $1.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -840.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -494.13 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1.48 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -203.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -65.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Sep 30, 2024 | 1.00 |
| Sep 30, 2024 | 1.00 |
| Mar 31, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | -2,501.00 |
| Dec 31, 2023 | -2,501.00 |
| Sep 30, 2023 | -665,198.00 |
| Sep 30, 2023 | -665,198.00 |
| Jun 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | -1.00 Mn |
| Mar 31, 2023 | -1.00 Mn |
| Dec 31, 2022 | -1.13 Mn |
| Dec 31, 2022 | -1.13 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |